Topical therapeutic for Bacterial Vaginosis (BV)

Drug discovery and biotech · by Matrubials, Inc.

Topical therapeutic in development for Bacterial Vaginosis (BV), the company's first indication, targeting recurrent infections and associated complications in women of reproductive ages.

What it does

Topical therapeutic in development for Bacterial Vaginosis (BV), the company's first indication, targeting recurrent infections and associated complications in women of reproductive ages.

  • Novel antibacterial therapeutics to address non-selectivity and emerging antimicrobial resistance
Category
Drug discovery and biotech
Public API
Not offered

Not yet disclosed: deployment options, platforms, languages and support channels.

Pricing

Pricing isn't published

Matrubials, Inc. doesn't list prices publicly. Ask them for a quote.

Security and compliance

No security details published yet

Matrubials, Inc. hasn't published certifications or security practices for Topical therapeutic for Bacterial Vaginosis (BV) that we could find. Ask their team for audit reports.

Reviews

No reviews yet

Reviews come from people who use Topical therapeutic for Bacterial Vaginosis (BV) at work. Share how your team uses it to help other buyers decide.

Alternatives

Is this your product?

Claim it to keep details accurate and submit evidence for the next ranking review.

Claim Topical therapeutic for Bacterial Vaginosis (BV)